Use of colony-stimulating factors in the treatment of neutropenia associated with collagen vascular disease

Current Opinion in Hematology

Volumn 4, Issue 3, 1997, Pages 196-199

  Starkebaum, Gordon ^a  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

COLLAGEN DISEASE; DRUG EFFICACY; DRUG TOLERABILITY; FELTY SYNDROME; LEUKOCYTOCLASTIC VASCULITIS; NEUTROPENIA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SHORT SURVEY; VASCULAR DISEASE;

EID: 0030808239     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199704030-00007     Document Type: Short Survey

References (46)

1. Campion G, Maddison PJ, Goulding N, James I, Ahern MJ, Watt I, Sansom D: The Felty syndrome: a case-matched study of clinical manifestations and outcome, serologic features, and immunogenetic associations. Medicine (Baltimore) 1990, 69:69-80.
2. Loughran TP, Jr: Clonal diseases of large granular lymphocytes. Blood 1993, 82:1-14.
3. Bowman SJ, Sivakumaran M, Snowden N, Bhavnani M, Hall MA, Panayi GS: The large granular lymphocyte syndrome with rheumatoid arthritis: immunogenetic evidence for a broader definition of Felty's syndrome. Arthritis Rheum 1994, 37:1326-1330. This paper shows that nearly all patients with RA and the lymphoproliferative syndrome of large granular lymphocytes (LGL) were DR4 positive, similar to the DR4 association in Felty's syndrome, whereas patients with the LGL syndrome without RA had a normal DR4 frequency. The authors propose that Felty's syndrome and the LGL syndrome with RA represent variations of a single syndrome.
4. Starkebaum G, Singer JW, Arend WP: Humoral and cellular immune mechanisms of neutropenia in patients with Felty's syndrome. Clin Exp Immunol 1980, 39:307-314.
5. Abdou NI: Heterogeneity of bone marrow-directed immune mechanisms in the pathogenesis of neutropenia of Felty's syndrome. Arthritis Rheum 1983, 26:947-953.
6. Breedveld FC, Lafeber GJ, De Vries E, van Krieken JH, Cats A: Immune complexes and the pathogenesis of neutropenia in Felty's syndrome. Ann Rheum Dis 1986, 45:696-702.
7. Bhalla K, Ross R, Jeter E, Madyastha P, Stuart R: G-CSF improves granulocytopenia in Felty's syndrome without flare-up of arthritis [letter]. Am J Hematol 1993, 42:230-231.
8. Marfeuille M, Clerc D, Mariette X: Successful treatment of agranulocytosis and sepsis with granulocyte colony stimulating factor in a case of Felty's syndrome [letter; comment]. J Rheumatol 1995, 22:1803-1804.
9. Fohlman J, Hoglund M, Bergmann S: Successful treatment of chronic wound infection in neutropenia and rheumatoid arthritis with filgrastim (rhG-GSF). Ann Hematol 1994, 69:153-156.
10. Moore DF Jr, Vadhan Raj S: Sustained response in Felty's syndrome to prolonged administration of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF). Am J Med 1995, 98:591-594. A good review of clinical responses to CSFs in Felty's syndrome.
11. Wagner DR, Combe C, Gresser U: GM-CSF and G-CSF in Felty's syndrome. Clin Investig 1993, 71:168-171.
12. Wandt H, Seifert M, Falge C, Gallmeier WM: Long-term correction of neutropenia in Felty's syndrome with granulocyte colony-stimulating factor. Ann Hematol 1993, 66:265-266.
13. Fraser DD, Sartiano GP, Butler TW, Treadwell EL: Neutropenia of Felty's syndrome successfully treated with granulocyte colony stimulating factor [letter]. J Rheumatol 1993, 20:1447-1448.
14. Graham KE, Coodley GO: A prolonged use of granulocyte colony stimulating factor in Felty's syndrome. J Rheumatol 1995, 22:174-176.
15. Weide R, Heymanns J. Koppler H, Tiemann M, Huss B, Pfluger KH, Havemann K: Successful treatment of neutropenia in T-LGL leukemia (T gamma-lymphocytosis) with granulocyte colony-stimulating factor. Ann Hematol 1994, 69:117-119.
16. Stanworth SJ, Green L, Pumphrey RS, Swinson DR, Bhavnani M: An unusual association of Felty syndrome and TCR gamma delta lymphocytosis. J Clin Pathol 1996, 49:351-353.
17. Lamy T, LePrise PY, Amiot L, Drenou B, Fauchet R, Genetet N, Semana G: Response to granulocyte-macrophage colony-stimulating factor (GM-CSF) but not to G-CSF in a case of agranulocytosis associated with large granular lymphocyte (LGL) leukemia [letter]. Blood 1995, 85:3352-3353.
18. Seebach J, Speich R, Fehr J, Tuchschmid P, Russi E: GM-CSF-induced acute eosinophilic pneumonia. Br J Haematol 1995, 90:963-965.
19. Loughran TP, Jr, Kidd PG, Starkebaum G: Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate. Blood 1994, 84:2164-2170.
20. Pixley JS, Yoneda KY, Manalo PB: Sequential administration of cyclophosphamide and granulocyte-colony stimulating factor relieves impaired myeloid maturation in Felly's syndrome. Am J Hematol 1993, 43:304-306.
21. Yoshioka K: Combined therapy of Q-CSF and prednisolone for neutropenia in a patient with Felty's syndrome [letter]. Am J Hematol 1995, 48:130-131.
22. Hoshina Y, Moriuchi J, Nakamura Y, Arimori S, Ichikawa Y: CD4+ T cell-mediated leukopenia of Felty's syndrome successfully treated with granulocyte-colony-stimulating factor and methotrexate. Arthritis Rheum 1994, 37:298-299.
23. Jakubowski A, Winton EF, Gencarelli A, Gabrilove J: Treatment of chronic neutropenia associated with large granular lymphocytosis with cyclosporine A and filgrastim. Am J Hematol 1995, 50:288-291.
24. Schwab UM, Harten P, Zeuner RA, Kulper M, Euler HH: G-CSF in patients with lupus-associated neutropenia and infections [in German]. Z Rheumatol 1996, 55:174-179.
25. McMullin MF, Finch MB: Felty's syndrome treated with rhG-CSF associated with flare of arthritis and skin rash. Clin Rheumatol 1995, 14:204-208.
26. Hayat SQ, Hearth Holmes M, Wolf RE: Flare of arthritis with successful treatment of Felty's syndrome with granulocyte colony stimulating factor (G-CSF). Clin Rheumatol 1995, 14:211-212.
27. Yasuda M, Kihara T, Wada T, Shiokawa S, Furuta E, Suenagu Y, Nonaka S, Nobunaga M, Yoshiok K, Isayama T: Granulocyte colony-stimulating factor induction of improved leukocytopenia with inflammatory flare in a Felty's syndrome patient. Arthritis Rheum 1994, 37:145-146.
28. Pereira J, Velloso ED, Loterio HA, Laurindo IM, Chamone DA: Long-term remission of neutropenia in Felty's syndrome after a short GM-CSF treatment. Acta Haematol 1994, 92:154-156.
29. Farhey YD, Herman JH: Vasculitis complicating granulocyte colony stimulating factor treatment of leukopenia and infection in Felty's syndrome. J Rheumatol 1995, 22:1179-1182.
30. Vidarsson B, Geirsson AJ, Onundarson PT: Reactivation of rheumatoid arthritis and development of leukocytoclastic vasculitis in a patient receiving granulocyte colony-stimulating factor for Felty's syndrome. Am J Med 1995, 98:589-591.
31. Nakashima H, Kawabe K, Ohtsuka T, Hayashida K, Horiuchi T, Nagasawa K, Niho Y: Rheumatoid arthritis exacerbation by G-CSF treatment for bucillamine-induced agranulocytosis [letter]. Clin Exp Rheumatol 1995, 13:677-679.
32. Jain KK: Cutaneous vasculitis associated with granulocyte colony-stimulating factor. J Am Acad Dermatol 1994, 31:213-215.
33. Hazenberg BP, Van Leeuwen MA, Van Rijswijk MH, Stern AC, Vellenga E: Correction of granulocytopenia in Felty's syndrome by granulocyte-macrophage colony-stimulating factor: simultaneous induction of interleukin-6 release and flare-up of the arthritis. Blood 1989, 74:2769-2770.
34. van Pelt LJ, Huisman MV, Weening RS, von dem Borne AE, Roos D, van Oers RH: A single dose of granulocyte-macrophage colony-stimulating factor induces systemic interleukin-8 release and neutrophil activation in healthy volunteers. Blood 1996, 87:5305-5313.
35. Xu S, Hoglund M, Venge P: The effect of granulocyte colony-stimulating factor (G-CSF) on the degranulation of secondary granule proteins from human neutrophils in vivo may be indirect. Br J Haematol 1996, 93:558-568.
36. de Haas M, Kerst JM, van der Schoot CE, Calafat J, Hack CE, Nuijens JH, Roos D, van Oers RH, von dem Borne AE: Granulocyte colony-stimulating factor administration to healthy volunteers: analysis of the immediate activating effects on circulating neutrophils. Blood 1994, 84:3885-3894.
37. Hurd ER, Chubick A, Jasin HE, Ziff M: Increased C1q binding immune complexes in Felty's syndrome: comparison with uncomplicated rheumatoid arthritis. Arthritis Rheum 1979, 22:697-702.
38. Starkebaum G, Arend WP, Nardella FA, Gavin SE: Characterization of immune complexes and immunoglobulin G antibodies reactive with neutrophils in the sera of patients with Felty's syndrome. J Lab Clin Med 1980, 96:238-251.
39. Starkebaum G, Arend WP: Neutrophil-binding immunoglobulin G in systemic lupus erythematosus. J Clin Invest 1979, 64:902-912.
40. Qasim FJ, Mathieson PW, Sendo F, Thiru S, Oliveira DB: Role of neutrophils in the pathogenesis of experimental vasculitis. Am J Pathol 1996, 149:81-89.
41. Wun T: The Felty syndrome and G-CSF - associated thrombocytopenia and severe anemia [letter]. Ann Intern Med 1993, 118:318-319.
42. Bonilla MA, Dale D, Zeidler C, Last L, Reiter A, Ruggeiro M, Davis M, Koci B, Hammond W, Gillio A, et al.: Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG CSF) in patients with severe congenital neutropenias. Br J Haematol 1994, 88:723-730.
43. Bishop NJ, Williams DM, Compston JC, Stirling DM, Prentice A: Osteoporosis in severe congenital neutropenia treated with granulocyte colony-stimulating factor. Br J Haematol 1995, 89:927-928.
44. Vial T, Descotes J: Clinical toxicity of cytokines used as haemopoietic growth factors. Drug Saf 1995, 13:371-406. A comprehensive review of side effects associated with use of CSFs.
45. Anderlini P, Przepiorka D, Champlin R, Korbling M: Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood 1996, 88:2819-2825. A useful review of the reported effects of G-CSF used in normal indivduals.
46. Breedveld FC, Fibbe WE, Hermans J, van Dermeer JW, Cats A: Factors influencing the incidence of infections in Felty's syndrome. Arch Intern Med 1987, 147:915-920.